| IPOYX | RNWBX | IPOYX / RNWBX | |
| Total Expense Ratio | 1.05 | 1.67 | 63% |
| Annual Report Gross Expense Ratio | 1.49 | 1.67 | 89% |
| Fund Existence | 22 years | 23 years | - |
| Gain YTD | 26.204 | 27.152 | 97% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 696M | 76.3B | 1% |
| Annual Yield % from dividends | 2.65 | 0.12 | 2,261% |
| Returns for 1 year | 25.64 | 20.32 | 126% |
| Returns for 3 years | 34.27 | 47.10 | 73% |
| Returns for 5 years | -0.09 | 21.37 | -0% |
| Returns for 10 years | 83.40 | 93.86 | 89% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IQSI | 35.04 | 0.18 | +0.51% |
| NYLI Candriam International Equity ETF | |||
| VXUS | 75.82 | 0.29 | +0.38% |
| Vanguard Total International Stock ETF | |||
| IBBQ | 27.58 | 0.07 | +0.24% |
| Invesco Nasdaq Biotechnology ETF | |||
| FNOV | 53.91 | 0.01 | +0.02% |
| FT Vest US Equity Buffer ETF Nov | |||
| SMCY | 11.00 | -0.24 | -2.14% |
| YieldMax SMCI Option Income Strategy ETF | |||